{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:47:34Z","timestamp":1792792054268,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02759-5","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:24:25Z","timestamp":1782469465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular mechanism of allosteric modulation of opioid receptors"],"prefix":"10.1038","volume":"11","author":[{"given":"Heli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0577-0130","authenticated-orcid":false,"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6771-1187","authenticated-orcid":false,"given":"Xihao","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lantian","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3885-543X","authenticated-orcid":false,"given":"Renjie","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7204-801X","authenticated-orcid":false,"given":"Zhenhua","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"2759_CR1","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1021\/acschemneuro.7b00195","volume":"8","author":"G Del Vecchio","year":"2017","unstructured":"Del Vecchio, G., Spahn, V. & Stein, C. Novel opioid analgesics and side effects. ACS Chem. Neurosci. 8, 1638\u20131640 (2017).","journal-title":"ACS Chem. Neurosci."},{"key":"2759_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pbb.2013.10.018","volume":"123","author":"RC Crist","year":"2014","unstructured":"Crist, R. C. & Berrettini, W. H. Pharmacogenetics of OPRM1. Pharmacol. Biochem. Behav. 123, 25\u201333 (2014).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"2759_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cell.2017.11.033","volume":"172","author":"AS Hauser","year":"2018","unstructured":"Hauser, A. S. et al. Pharmacogenomics of GPCR Drug Targets. Cell 172, 41\u201354 (2018).","journal-title":"Cell"},{"key":"2759_CR4","first-page":"1","volume":"No.522","author":"MF Garnett","year":"2024","unstructured":"Garnett, M. F. & Minino, A. M. Drug overdose deaths in the United States, 2003\u20132023. NCHS Data Brief No.522, 1\u201312 (2024).","journal-title":"NCHS Data Brief"},{"key":"2759_CR5","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1021\/acs.jcim.0c00890","volume":"61","author":"A Ricarte","year":"2021","unstructured":"Ricarte, A., Dalton, J. A. R. & Giraldo, J. Structural assessment of agonist efficacy in the \u03bc-opioid receptor: morphine and fentanyl elicit different activation patterns. J. Chem. Inf. Model. 61, 1251\u20131274 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"2759_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.apsb.2023.07.020","volume":"14","author":"C Zhu","year":"2024","unstructured":"Zhu, C., Lan, X., Wei, Z., Yu, J. & Zhang, J. Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain. Acta Pharm. Sin. B 14, 67\u201386 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"2759_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-clinpsy-081423-023518","volume":"21","author":"S Martinez","year":"2025","unstructured":"Martinez, S., Ellis, J. D., Bergeria, C. L., Huhn, A. S. & Dunn, K. E. Treating opioid use disorder and opioid withdrawal in the context of fentanyl. Annu. Rev. Clin. Psychol. 21, 221\u2013249 (2025).","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"2759_CR8","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/s41562-025-02156-y","volume":"9","author":"M Fillingim","year":"2025","unstructured":"Fillingim, M. et al. Biological markers and psychosocial factors predict chronic pain conditions. Nat. Hum. Behav. 9, 1710\u20131725 (2025).","journal-title":"Nat. Hum. Behav."},{"key":"2759_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2147\/JMDH.S288401","volume":"14","author":"T Mallick-Searle","year":"2021","unstructured":"Mallick-Searle, T., Sharma, K., Toal, P. & Gutman, A. Pain and function in chronic musculoskeletal pain-treating the whole person. J. Multidiscip. Healthc. 14, 335\u2013347 (2021).","journal-title":"J. Multidiscip. Healthc."},{"key":"2759_CR10","doi-asserted-by":"publisher","first-page":"e70014","DOI":"10.1002\/sen2.70014","volume":"1","author":"P Muthuirulan","year":"2025","unstructured":"Muthuirulan, P., Nityanand, A., Pandit, A. & Gururajan, V. Regenerating the senses: stem cell-derived sensory neurons and functional genomics in neurological disorders. Sens. Neurosci. 1, e70014 (2025).","journal-title":"Sens. Neurosci."},{"key":"2759_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43556-023-00156-w","volume":"4","author":"L Cheng","year":"2023","unstructured":"Cheng, L. et al. Structure, function and drug discovery of GPCR signaling. Mol. Biomed. 4, 46 (2023).","journal-title":"Mol. Biomed."},{"key":"2759_CR12","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1111\/bph.13809","volume":"175","author":"T Gunther","year":"2018","unstructured":"Gunther, T. et al. Targeting multiple opioid receptors\u2014improved analgesics with reduced side effects?. Br. J. Pharmacol. 175, 2857\u20132868 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"2759_CR13","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1016\/j.cell.2023.10.029","volume":"186","author":"T Che","year":"2023","unstructured":"Che, T. & Roth, B. L. Molecular basis of opioid receptor signaling. Cell 186, 5203\u20135219 (2023).","journal-title":"Cell"},{"key":"2759_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","volume":"67","author":"C Stein","year":"2016","unstructured":"Stein, C. Opioid receptors. Annu. Rev. Med. 67, 433\u2013451 (2016).","journal-title":"Annu. Rev. Med."},{"key":"2759_CR15","doi-asserted-by":"publisher","first-page":"129552","DOI":"10.52965\/001c.129552","volume":"13","author":"P Brown","year":"2025","unstructured":"Brown, P. et al. Methadone for chronic pain: a review of pharmacology, efficacy, and safety concerns. Health Psychol. Res. 13, 129552 (2025).","journal-title":"Health Psychol. Res."},{"key":"2759_CR16","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.119156","volume":"11","author":"AN Edinoff","year":"2021","unstructured":"Edinoff, A. N. et al. Full opioid agonists and tramadol: pharmacological and clinical considerations. Anesth. Pain Med. 11, e119156 (2021).","journal-title":"Anesth. Pain Med."},{"key":"2759_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2165\/11589080-000000000-00000","volume":"25","author":"CT Hartrick","year":"2011","unstructured":"Hartrick, C. T. & Rozek, R. J. Tapentadol in pain management: a \u03bc-opioid receptor agonist and noradrenaline reuptake inhibitor. CNS Drugs 25, 359\u2013370 (2011).","journal-title":"CNS Drugs"},{"key":"2759_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s40263-014-0151-9","volume":"28","author":"TM Tzschentke","year":"2014","unstructured":"Tzschentke, T. M., Christoph, T. & Kogel, B. Y. The mu-opioid receptor agonist\/noradrenaline reuptake inhibition (MOR-NRI) concept in analgesia: the case of tapentadol. CNS Drugs 28, 319\u2013329 (2014).","journal-title":"CNS Drugs"},{"key":"2759_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1124\/jpet.114.213694","volume":"349","author":"K Linz","year":"2014","unstructured":"Linz, K. et al. Cebranopadol: a novel potent analgesic nociceptin\/orphanin FQ peptide and opioid receptor agonist. J. Pharmacol. Exp. Ther. 349, 535\u2013548 (2014).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2759_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.110048","volume":"257","author":"N Cannella","year":"2024","unstructured":"Cannella, N. et al. Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: preclinical evidence of efficacy. Neuropharmacology 257, 110048 (2024).","journal-title":"Neuropharmacology"},{"key":"2759_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJMra1800222","volume":"380","author":"JAJ Martyn","year":"2019","unstructured":"Martyn, J. A. J., Mao, J. & Bittner, E. A. Opioid tolerance in critical illness. N. Engl. J. Med. 380, 365\u2013378 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2759_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/pr.112.005942","volume":"65","author":"JT Williams","year":"2013","unstructured":"Williams, J. T. et al. Regulation of \u03bc-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol. Rev. 65, 223\u2013254 (2013).","journal-title":"Pharmacol. Rev."},{"key":"2759_CR23","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1146\/annurev-biochem-061620-044044","volume":"90","author":"T Che","year":"2021","unstructured":"Che, T. & Roth, B. L. Structural insights accelerate the discovery of opioid alternatives. Annu. Rev. Biochem. 90, 739\u2013761 (2021).","journal-title":"Annu. Rev. Biochem."},{"key":"2759_CR24","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1016\/j.cell.2025.04.038","volume":"188","author":"R Guo","year":"2025","unstructured":"Guo, R. et al. Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic pain. Cell 188, 4332\u20134349 (2025).","journal-title":"Cell"},{"key":"2759_CR25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2321532121","volume":"121","author":"S Shen","year":"2024","unstructured":"Shen, S. et al. Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1. Proc. Natl. Acad. Sci. USA 121, e2321532121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2759_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tibs.2014.03.002","volume":"39","author":"V Katritch","year":"2014","unstructured":"Katritch, V. et al. Allosteric sodium in class A GPCR signaling. Trends Biochem. Sci. 39, 233\u2013244 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"2759_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature12944","volume":"506","author":"G Fenalti","year":"2014","unstructured":"Fenalti, G. et al. Molecular control of \u03b4-opioid receptor signalling. Nature 506, 191\u2013196 (2014).","journal-title":"Nature"},{"key":"2759_CR28","doi-asserted-by":"publisher","first-page":"G66","DOI":"10.1152\/ajpgi.00297.2021","volume":"322","author":"JJ DiCello","year":"2022","unstructured":"DiCello, J. J. et al. Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disorders. Am. J. Physiol. Gastrointest. Liver Physiol. 322, G66\u2013G78 (2022).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2759_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2000017118","volume":"118","author":"R Kandasamy","year":"2021","unstructured":"Kandasamy, R. et al. Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects. Proc. Natl. Acad. Sci. USA 118, e2000017118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2759_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108673","volume":"195","author":"KD Pryce","year":"2021","unstructured":"Pryce, K. D. et al. A promising chemical series of positive allosteric modulators of the \u03bc-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects. Neuropharmacology 195, 108673 (2021).","journal-title":"Neuropharmacology"},{"key":"2759_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/joacp.JOACP_362_19","volume":"38","author":"B Ghai","year":"2022","unstructured":"Ghai, B. et al. Opioid sparing strategies for perioperative pain management other than regional anaesthesia: a narrative review. J. Anaesthesiol. Clin. Pharmacol. 38, 3\u201310 (2022).","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"key":"2759_CR32","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.2147\/JPR.S506147","volume":"18","author":"M Xiong","year":"2025","unstructured":"Xiong, M. et al. Opioid-free versus opioid-sparing anesthesia for postoperative pain and early recovery after laparoscopic cholecystectomy: a randomized controlled trial. J. Pain Res. 18, 2137\u20132146 (2025).","journal-title":"J. Pain Res."},{"key":"2759_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.sbi.2020.01.010","volume":"62","author":"E Guarnera","year":"2020","unstructured":"Guarnera, E. & Berezovsky, I. N. Allosteric drugs and mutations: chances, challenges, and necessity. Curr. Opin. Struct. Biol. 62, 149\u2013157 (2020).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2759_CR34","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.bmcl.2010.01.109","volume":"20","author":"TM Bridges","year":"2010","unstructured":"Bridges, T. M. et al. Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: development of a potent and highly selective M1 PAM. Bioorg. Med. Chem. Lett. 20, 1972\u20131975 (2010).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2759_CR35","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1111\/bph.14602","volume":"176","author":"MA Stanczyk","year":"2019","unstructured":"Stanczyk, M. A. et al. The \u03b4-opioid receptor positive allosteric modulator BMS 986187 is a G-protein-biased allosteric agonist. Br. J. Pharmacol. 176, 1649\u20131663 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"2759_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1124\/mol.117.109561","volume":"93","author":"KE Livingston","year":"2018","unstructured":"Livingston, K. E. et al. Pharmacologic evidence for a putative conserved allosteric site on opioid receptors. Mol. Pharmacol. 93, 157\u2013167 (2018).","journal-title":"Mol. Pharmacol."},{"key":"2759_CR37","doi-asserted-by":"publisher","first-page":"10830","DOI":"10.1073\/pnas.1300393110","volume":"110","author":"NT Burford","year":"2013","unstructured":"Burford, N. T. et al. Discovery of positive allosteric modulators and silent allosteric modulators of the \u03bc-opioid receptor. Proc. Natl. Acad. Sci. USA 110, 10830\u201310835 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2759_CR38","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41586-021-03897-2","volume":"597","author":"CJ Draper-Joyce","year":"2021","unstructured":"Draper-Joyce, C. J. et al. Positive allosteric mechanisms of adenosine A1 receptor-mediated analgesia. Nature 597, 571\u2013576 (2021).","journal-title":"Nature"},{"key":"2759_CR39","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/npp.2009.194","volume":"35","author":"K Leach","year":"2010","unstructured":"Leach, K. et al. Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties. Neuropsychopharmacology 35, 855\u2013869 (2010).","journal-title":"Neuropsychopharmacology"},{"key":"2759_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.tips.2007.06.004","volume":"28","author":"K Leach","year":"2007","unstructured":"Leach, K., Sexton, P. M. & Christopoulos, A. Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology. Trends Pharmacol. Sci. 28, 382\u2013389 (2007).","journal-title":"Trends Pharmacol. Sci."},{"key":"2759_CR41","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41392-023-01625-y","volume":"8","author":"L Cheng","year":"2023","unstructured":"Cheng, L. et al. Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2. Signal Transduct. Target. Ther. 8, 364 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2759_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47792-6","volume":"15","author":"S Kaneko","year":"2024","unstructured":"Kaneko, S. et al. Structural and dynamic insights into the activation of the \u03bc-opioid receptor by an allosteric modulator. Nat. Commun. 15, 3544 (2024).","journal-title":"Nat. Commun."},{"key":"2759_CR43","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41589-022-01038-y","volume":"18","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1. Nat. Chem. Biol. 18, 831\u2013840 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"2759_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tips.2014.11.001","volume":"36","author":"V Isberg","year":"2015","unstructured":"Isberg, V. et al. Generic GPCR residue numbers\u2014aligning topology maps while minding the gaps. Trends Pharmacol. Sci. 36, 22\u201331 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"2759_CR45","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1021\/acs.jmedchem.5b00007","volume":"58","author":"NT Burford","year":"2015","unstructured":"Burford, N. T. et al. Discovery, synthesis, and molecular pharmacology of selective positive allosteric modulators of the \u03b4-opioid receptor. J. Med. Chem. 58, 4220\u20134229 (2015).","journal-title":"J. Med. Chem."},{"key":"2759_CR46","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1126\/science.1150577","volume":"318","author":"V Cherezov","year":"2007","unstructured":"Cherezov, V. et al. High-resolution crystal structure of an engineered human \u03b22-adrenergic G protein-coupled receptor. Science 318, 1258\u20131265 (2007).","journal-title":"Science"},{"key":"2759_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-3-030-14265-0_5","volume":"1135","author":"S Kiriakidi","year":"2019","unstructured":"Kiriakidi, S. et al. Effects of cholesterol on GPCR function: insights from computational and experimental studies. Adv. Exp. Med. Biol. 1135, 89\u2013103 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2759_CR48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature19112","volume":"537","author":"A Manglik","year":"2016","unstructured":"Manglik, A. et al. Structure-based discovery of opioid analgesics with reduced side effects. Nature 537, 185\u2013190 (2016).","journal-title":"Nature"},{"key":"2759_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/bph.12599","volume":"172","author":"NT Burford","year":"2015","unstructured":"Burford, N. T., Traynor, J. R. & Alt, A. Positive allosteric modulators of the \u03bc-opioid receptor: a novel approach for future pain medications. Br. J. Pharmacol. 172, 277\u2013286 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"2759_CR50","doi-asserted-by":"publisher","first-page":"116686","DOI":"10.1016\/j.bcp.2024.116686","volume":"232","author":"W Krol","year":"2025","unstructured":"Krol, W., Machelak, W. & Zielinska, M. Positive allosteric modulation of micro-opioid receptor\u2014a new possible approach in the pain management? Biochem. Pharmacol. 232, 116686 (2025).","journal-title":"Biochem. Pharmacol."},{"key":"2759_CR51","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1097\/ALN.0b013e318231fc11","volume":"115","author":"S Mahmoud","year":"2011","unstructured":"Mahmoud, S. et al. Pharmacological consequence of the A118G mu opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca2+ channels in humanized mouse sensory neurons. Anesthesiology 115, 1054\u20131062 (2011).","journal-title":"Anesthesiology"},{"key":"2759_CR52","doi-asserted-by":"publisher","first-page":"6530","DOI":"10.1074\/jbc.M807030200","volume":"284","author":"BG Oertel","year":"2009","unstructured":"Oertel, B. G. et al. A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. J. Biol. Chem. 284, 6530\u20136535 (2009).","journal-title":"J. Biol. Chem."},{"key":"2759_CR53","first-page":"1","volume":"No.457","author":"MR Spencer","year":"2022","unstructured":"Spencer, M. R., Minino, A. M. & Warner, M. Drug overdose deaths in the United States, 2001-2021. NCHS Data Brief No.457, 1\u20138 (2022).","journal-title":"NCHS Data Brief"},{"key":"2759_CR54","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/S2468-2667(24)00001-X","volume":"9","author":"A Holland","year":"2024","unstructured":"Holland, A. et al. Nitazenes-heralding a second wave for the UK drug-related death crisis? Lancet Public Health 9, e71\u2013e72 (2024).","journal-title":"Lancet Public Health"},{"key":"2759_CR55","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41586-024-07587-7","volume":"631","author":"ES O\u2019Brien","year":"2024","unstructured":"O\u2019Brien, E. S. et al. A micro-opioid receptor modulator that works cooperatively with naloxone. Nature 631, 686\u2013693 (2024).","journal-title":"Nature"},{"key":"2759_CR56","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41386-018-0292-5","volume":"44","author":"K Rasmussen","year":"2019","unstructured":"Rasmussen, K., White, D. A. & Acri, J. B. NIDA\u2019s medication development priorities in response to the Opioid Crisis: ten most wanted. Neuropsychopharmacology 44, 657\u2013659 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"2759_CR57","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/bph.15760","volume":"180","author":"BR Varga","year":"2023","unstructured":"Varga, B. R., Streicher, J. M. & Majumdar, S. Strategies towards safer opioid analgesics\u2014a review of old and upcoming targets. Br. J. Pharmacol. 180, 975\u2013993 (2023).","journal-title":"Br. J. Pharmacol."},{"key":"2759_CR58","doi-asserted-by":"publisher","first-page":"E2419","DOI":"10.1073\/pnas.1718037115","volume":"115","author":"M Korczynska","year":"2018","unstructured":"Korczynska, M. et al. Structure-based discovery of selective positive allosteric modulators of antagonists for the M2 muscarinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA 115, E2419\u2013E2428 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2759_CR59","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cell.2021.01.028","volume":"184","author":"P Xiao","year":"2021","unstructured":"Xiao, P. et al. Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes. Cell 184, 943\u2013956 (2021).","journal-title":"Cell"},{"key":"2759_CR60","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","volume":"186","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Structures of the entire human opioid receptor family. Cell 186, 413\u2013427 (2023).","journal-title":"Cell"},{"key":"2759_CR61","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1021\/acschembio.5b00712","volume":"11","author":"Y Shang","year":"2016","unstructured":"Shang, Y. et al. Proposed mode of binding and action of positive allosteric modulators at opioid receptors. ACS Chem. Biol. 11, 1220\u20131229 (2016).","journal-title":"ACS Chem. Biol."},{"key":"2759_CR62","doi-asserted-by":"publisher","first-page":"18369","DOI":"10.1073\/pnas.1415013111","volume":"111","author":"KE Livingston","year":"2014","unstructured":"Livingston, K. E. & Traynor, J. R. Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor. Proc. Natl. Acad. Sci. USA 111, 18369\u201318374 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2759_CR63","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41586-022-05588-y","volume":"613","author":"A Faouzi","year":"2023","unstructured":"Faouzi, A. et al. Structure-based design of bitopic ligands for the micro-opioid receptor. Nature 613, 767\u2013774 (2023).","journal-title":"Nature"},{"key":"2759_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52601-1","volume":"15","author":"L Cheng","year":"2024","unstructured":"Cheng, L. et al. Cryo-EM structure of small-molecule agonist bound delta opioid receptor-Gi complex enables discovery of biased compound. Nat. Commun. 15, 8284 (2024).","journal-title":"Nat. Commun."},{"key":"2759_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37041-7","volume":"14","author":"A El Daibani","year":"2023","unstructured":"El Daibani, A. et al. Molecular mechanism of biased signaling at the kappa opioid receptor. Nat. Commun. 14, 1338 (2023).","journal-title":"Nat. Commun."},{"key":"2759_CR66","doi-asserted-by":"publisher","first-page":"985.5","DOI":"10.1096\/fasebj.31.1_supplement.985.5","volume":"31","author":"IJ Dripps","year":"2017","unstructured":"Dripps, I. J., Boyer, B., Traynor, J. & Jutkiewicz, E. In vivo characterization of the novel delta opioid receptor positive allosteric modulator BMS-986187. FASEB J. 31, 985.5 (2017).","journal-title":"FASEB J."},{"key":"2759_CR67","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/aps.2010.138","volume":"31","author":"YH Wang","year":"2010","unstructured":"Wang, Y. H., Sun, J. F., Tao, Y. M., Chi, Z. Q. & Liu, J. G. The role of \u03ba-opioid receptor activation in mediating antinociception and addiction. Acta Pharmacol. Sin. 31, 1065\u20131070 (2010).","journal-title":"Acta Pharmacol. Sin."},{"key":"2759_CR68","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1021\/acs.biochem.4c00877","volume":"64","author":"C Wu","year":"2025","unstructured":"Wu, C. et al. Pharmacological characterization of dopamine receptor DRD1 variants and exploration of their allosteric activation. Biochemistry 64, 2200\u20132211 (2025).","journal-title":"Biochemistry"},{"key":"2759_CR69","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","volume":"619","author":"D Kim","year":"2023","unstructured":"Kim, D. et al. Pan-KRAS inhibitor disables oncogenic signalling and tumour growth. Nature 619, 160\u2013166 (2023).","journal-title":"Nature"},{"key":"2759_CR70","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/aps.2016.69","volume":"37","author":"P Liu","year":"2016","unstructured":"Liu, P. et al. The structural basis of the dominant negative phenotype of the G\u03b1i1\u03b21\u03b32 G203A\/A326S heterotrimer. Acta Pharmacol. Sin. 37, 1259\u20131272 (2016).","journal-title":"Acta Pharmacol. Sin."},{"key":"2759_CR71","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41586-023-06804-z","volume":"624","author":"Z Xu","year":"2023","unstructured":"Xu, Z. et al. Ligand recognition and G-protein coupling of trace amine receptor TAAR1. Nature 624, 672\u2013681 (2023).","journal-title":"Nature"},{"key":"2759_CR72","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41422-023-00779-2","volume":"33","author":"Y Feng","year":"2023","unstructured":"Feng, Y. et al. Mechanism of activation and biased signaling in complement receptor C5aR1. Cell Res. 33, 312\u2013324 (2023).","journal-title":"Cell Res."},{"key":"2759_CR73","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"2759_CR74","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","volume":"16","author":"T Bepler","year":"2019","unstructured":"Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153\u20131160 (2019).","journal-title":"Nat. Methods"},{"key":"2759_CR75","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"2759_CR76","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","volume":"185","author":"Y Zhuang","year":"2022","unstructured":"Zhuang, Y. et al. Molecular recognition of morphine and fentanyl by the human \u03bc-opioid receptor. Cell 185, 4361\u20134375 (2022).","journal-title":"Cell"},{"key":"2759_CR77","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2759_CR78","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"2759_CR79","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MH Olsson","year":"2011","unstructured":"Olsson, M. H., Sondergaard, C. R., Rostkowski, M. & Jensen, J. H. PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions. J. Chem. Theory Comput. 7, 525\u2013537 (2011).","journal-title":"J. Chem. Theory Comput."},{"key":"2759_CR80","doi-asserted-by":"publisher","first-page":"D370","DOI":"10.1093\/nar\/gkr703","volume":"40","author":"MA Lomize","year":"2012","unstructured":"Lomize, M. A., Pogozheva, I. D., Joo, H., Mosberg, H. I. & Lomize, A. L. OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res. 40, D370\u2013D376 (2012).","journal-title":"Nucleic Acids Res."},{"key":"2759_CR81","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1021\/acs.jcim.9b00269","volume":"59","author":"S Schott-Verdugo","year":"2019","unstructured":"Schott-Verdugo, S. & Gohlke, H. PACKMOL-Memgen: a simple-to-use, generalized workflow for membrane-protein-lipid-bilayer system building. J. Chem. Inf. Model. 59, 2522\u20132528 (2019).","journal-title":"J. Chem. Inf. Model."},{"key":"2759_CR82","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","volume":"63","author":"DA Case","year":"2023","unstructured":"Case, D. A. et al. AmberTools. J. Chem. Inf. Model. 63, 6183\u20136191 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"2759_CR83","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian, C. et al. ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J. Chem. Theory Comput. 16, 528\u2013552 (2020).","journal-title":"J. Chem. Theory Comput."},{"key":"2759_CR84","doi-asserted-by":"publisher","first-page":"224108","DOI":"10.1063\/5.0004608","volume":"152","author":"F Neese","year":"2020","unstructured":"Neese, F., Wennmohs, F., Becker, U. & Riplinger, C. The ORCA quantum chemistry program package. J. Chem. Phys. 152, 224108 (2020).","journal-title":"J. Chem. Phys."},{"key":"2759_CR85","doi-asserted-by":"publisher","first-page":"082503","DOI":"10.1063\/5.0216272","volume":"161","author":"T Lu","year":"2024","unstructured":"Lu, T. A comprehensive electron wavefunction analysis toolbox for chemists. Multiwfn. J. Chem. Phys. 161, 082503 (2024).","journal-title":"Multiwfn. J. Chem. Phys."},{"key":"2759_CR86","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1021\/acs.jctc.1c01217","volume":"18","author":"CJ Dickson","year":"2022","unstructured":"Dickson, C. J., Walker, R. C. & Gould, I. R. Lipid21: complex lipid membrane simulations with AMBER. J. Chem. Theory Comput. 18, 1726\u20131736 (2022).","journal-title":"J. Chem. Theory Comput."},{"key":"2759_CR87","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1, 19\u201325 (2015).","journal-title":"SoftwareX"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02759-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02759-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02759-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:02:36Z","timestamp":1782475356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02759-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2759"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02759-5","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}